Dario Marchetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dario Marchetti has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Jane Reiland
Department of Comparative Biomedical Sciences-SVM, Louisiana State University-Baton Rouge, Baton Rouge, LA 70803, USA
6 shared publicationsMadhuchhanda Roy
6 shared publicationsBrian Murry
Louisiana State University School of Veterinary Medicine
3 shared publicationsBrian P. Murry
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University at Baton Rouge, Baton Rouge, Louisiana 70803, USA
3 shared publicationsJason Blust
Department of Comparative Biomedical Sciences, Louisiana State University School of Veterinary Medicine, Baton Rouge, LA 70803, USA
3 shared publicationsJennifer Galjour
Department of Comparative Biomedical Sciences, Louisiana State University School of Veterinary Medicine, Baton Rouge, LA 70803, USA
3 shared publications
Latest Publications
- 1 March 2007
- Vol. 26 (1) , 5-23
Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Medulloblastoma (MB) is the most common malignant brain tumor of childhood. Although modern therapy has produced five-year survival rates as high as 70% for some MB patients, this resulted in significant long-term treatment-related morbidity. The cellular mechanisms involved in metastatic spread of medulloblastoma are largely unknown. Neurotrophins (NT) comprise a family of structurally and functionally related neurotrophic factors that are critical for central nervous system (CNS) development with nerve growth factor (NGF) being the prototypic NT. NT acts through two groups of structurally unrelated neurotrophin receptors (NTR): a family of receptor tyrosine kinases (Trks, mainly TrkA, TrkB, and TrkC) and a tumor necrosis factor receptor (TNFR)-like molecule called p75NTR TrkC expression is a good prognostic indicator for MB. TrkC binds only to neurotrophin-3 (NT-3) whereas p75 binds to all NT family members. Importantly, little is known about the biological functions of p75 in primitive neuroectodermal tumors such as MB. In contrast, NT-regulated heparanase (HPSE) is a unique extracellular matrix-degrading enzyme known to be associated with tumor progression in a wide variety of cancers. However, HPSE roles in MB invasive pathways have not been investigated. We provide evidence of a differential expression of HPSE in newly-developed medulloblastoma cell lines. Secondly, we show a correlation between HPSE expression and the invasive properties of these medulloblastoma lines. Thirdly, by performing investigations to elucidate prognostic implications of HPSE and TrkC/p75NTR expression in MB, we demonstrate a correlation between p75NTR and HPSE expression. Finally, by using antibodies specific to TrkC and immunohistochemistry (IHC) we prove that IHC scores reveal a significant expression of HPSE in 76% of MB tissues from children aged 3 years and older. Taken together, our data provide evidence that HPSE functionality, in a context linked to TrkC and p75NTR activation, may play critical roles in medulloblastoma tumor invasion and progression.
- 1 March 2007
- Vol. 26 (1) , 5-23
Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Medulloblastoma (MB) is the most common malignant brain tumor of childhood. Although modern therapy has produced five-year survival rates as high as 70% for some MB patients, this resulted in significant long-term treatment-related morbidity. The cellular mechanisms involved in metastatic spread of medulloblastoma are largely unknown. Neurotrophins (NT) comprise a family of structurally and functionally related neurotrophic factors that are critical for central nervous system (CNS) development with nerve growth factor (NGF) being the prototypic NT. NT acts through two groups of structurally unrelated neurotrophin receptors (NTR): a family of receptor tyrosine kinases (Trks, mainly TrkA, TrkB, and TrkC) and a tumor necrosis factor receptor (TNFR)-like molecule called p75NTR TrkC expression is a good prognostic indicator for MB. TrkC binds only to neurotrophin-3 (NT-3) whereas p75 binds to all NT family members. Importantly, little is known about the biological functions of p75 in primitive neuroectodermal tumors such as MB. In contrast, NT-regulated heparanase (HPSE) is a unique extracellular matrix-degrading enzyme known to be associated with tumor progression in a wide variety of cancers. However, HPSE roles in MB invasive pathways have not been investigated. We provide evidence of a differential expression of HPSE in newly-developed medulloblastoma cell lines. Secondly, we show a correlation between HPSE expression and the invasive properties of these medulloblastoma lines. Thirdly, by performing investigations to elucidate prognostic implications of HPSE and TrkC/p75NTR expression in MB, we demonstrate a correlation between p75NTR and HPSE expression. Finally, by using antibodies specific to TrkC and immunohistochemistry (IHC) we prove that IHC scores reveal a significant expression of HPSE in 76% of MB tissues from children aged 3 years and older. Taken together, our data provide evidence that HPSE functionality, in a context linked to TrkC and p75NTR activation, may play critical roles in medulloblastoma tumor invasion and progression.
- Open Access
FGF2 Binding, Signaling, Angiogenesis Are Modulated by Heparanase in Metastatic Melanoma Cells
- 1 March 2006
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 23 (1) , 55-63
Heparanase Expression and TrkC/p75NTR Ratios in Human Medulloblastoma
Medulloblastoma (MB), the most devastating and common brain tumor in children, is highly invasive and extremely difficult to treat. Identifying the properties of MB tumors that cause them to invade and metastasize is therefore imperative for the development of novel treatments. We performed investigations to elucidate prognostic implications of heparanase (HPSE-1) and TrkC/p75NTR expression in MB using formalin-fixed, paraffin-embedded (FFPE) MB clinical specimens from children aged 1–19 years. Expressions of p75NTR and HPSE-1 correlated with each other (Pearson’s correlation R = 0.899; P < 0.0001; R 2 = 81%; n = 14). In addition, TrkC:p75NTR ratios correlated with MB meningeal spread (R = 0.608; P = 0.0212; R 2 = 37%; n = 14). Secondly, using antibodies specific to TrkC and HPSE-1, we carried out immunohistochemistry (IHC) on 22 human MB tissue samples. IHC reaction scores revealed a significant expression of HPSE-1 in 76% of MB tissues from children aged 3 years and older (P = 0.0490; n = 17) while TrkC immunoreactivity was detected in 71% of these patient samples. Of note, TrkC was significantly present in 100% of MB female patients (P = 0.0313; n = 6). These studies support the role of p75NTR and HPSE-1 as two novel molecular determinants involved in the biology and clinical progression of MB.
- 1 March 2006
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 23 (1) , 55-63
Heparanase Expression and TrkC/p75NTR Ratios in Human Medulloblastoma
Medulloblastoma (MB), the most devastating and common brain tumor in children, is highly invasive and extremely difficult to treat. Identifying the properties of MB tumors that cause them to invade and metastasize is therefore imperative for the development of novel treatments. We performed investigations to elucidate prognostic implications of heparanase (HPSE-1) and TrkC/p75NTR expression in MB using formalin-fixed, paraffin-embedded (FFPE) MB clinical specimens from children aged 1–19 years. Expressions of p75NTR and HPSE-1 correlated with each other (Pearson’s correlation R = 0.899; P < 0.0001; R 2 = 81%; n = 14). In addition, TrkC:p75NTR ratios correlated with MB meningeal spread (R = 0.608; P = 0.0212; R 2 = 37%; n = 14). Secondly, using antibodies specific to TrkC and HPSE-1, we carried out immunohistochemistry (IHC) on 22 human MB tissue samples. IHC reaction scores revealed a significant expression of HPSE-1 in 76% of MB tissues from children aged 3 years and older (P = 0.0490; n = 17) while TrkC immunoreactivity was detected in 71% of these patient samples. Of note, TrkC was significantly present in 100% of MB female patients (P = 0.0313; n = 6). These studies support the role of p75NTR and HPSE-1 as two novel molecular determinants involved in the biology and clinical progression of MB.
- 1 March 2006
- Published by Wiley in Journal of Neuroscience Research
- Vol. 83 (4) , 694-701
HPSE-1 expression and functionality in differentiating neural cells
The study of cellular differentiation encompasses many vital parts of biology and medicine. Heparan sulfate proteoglycans (HSPG) are essential and ubiquitous macromolecules associated with the cell surface and extracellular matrix (ECM) of a wide range of cells and tissues. Heparan sulfate chains (HS) of HSPG bind and sequester a multitude of extracellular ligands, including growth factors, cytokines, chemokines, enzymes, and lipoproteins. Enzymatic degradation of HS is therefore involved in processes such as cell proliferation, migration, and differentiation. Heparanase (HPSE‐1) is an HS degradative enzyme associated with inflammation and lipid metabolism and is a critical molecular determinant in cancer metastasis. The enzyme acts as an endo‐β‐D‐glucuronidase, which degrades HS at specific intrachain sites, resulting in HS fragments of discrete molecular weights that retain biological function. HPSE‐1's relevance as the only example of cloned/purified mammalian HS degradative enzyme led us to investigate its functionality in human olfactory epithelium (HOE) cells as a paradigm for HPSE‐1's roles in neural cell differentiation. We provide the first evidence of 1) HPSE‐1 presence in HOE cells and 2) a highly significant increase of HPSE‐1 mRNA and enzyme activity in differentiating vs. proliferating HOE cells. Our data suggest that an augmented HPSE‐1 activity may represent a physiological mechanism involved in neural cellular differentiation.
- 1 March 2006
- Published by Wiley in Journal of Neuroscience Research
- Vol. 83 (4) , 694-701
HPSE-1 expression and functionality in differentiating neural cells
The study of cellular differentiation encompasses many vital parts of biology and medicine. Heparan sulfate proteoglycans (HSPG) are essential and ubiquitous macromolecules associated with the cell surface and extracellular matrix (ECM) of a wide range of cells and tissues. Heparan sulfate chains (HS) of HSPG bind and sequester a multitude of extracellular ligands, including growth factors, cytokines, chemokines, enzymes, and lipoproteins. Enzymatic degradation of HS is therefore involved in processes such as cell proliferation, migration, and differentiation. Heparanase (HPSE‐1) is an HS degradative enzyme associated with inflammation and lipid metabolism and is a critical molecular determinant in cancer metastasis. The enzyme acts as an endo‐β‐D‐glucuronidase, which degrades HS at specific intrachain sites, resulting in HS fragments of discrete molecular weights that retain biological function. HPSE‐1's relevance as the only example of cloned/purified mammalian HS degradative enzyme led us to investigate its functionality in human olfactory epithelium (HOE) cells as a paradigm for HPSE‐1's roles in neural cell differentiation. We provide the first evidence of 1) HPSE‐1 presence in HOE cells and 2) a highly significant increase of HPSE‐1 mRNA and enzyme activity in differentiating vs. proliferating HOE cells. Our data suggest that an augmented HPSE‐1 activity may represent a physiological mechanism involved in neural cellular differentiation.
- 15 November 2005
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 97 (2) , 217-225
Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model
Heparanase (HPSE‐1) is an endo‐β‐D‐glucuronidase that cleaves heparan sulfate (HS) chains of proteoglycans (HSPG), and its expression has been associated with increased cell growth, invasion, and angiogenesis of tumors as well as with embryogenesis and tissue development. Since metastatic cancer cells express HPSE‐1, we have developed an orthotopic brain slice model to study HPSE‐1 involvement in brain‐metastatic melanoma. This model allows for the characterization of tumor cell invasion at both quantitative and qualitative levels. Brain‐metastatic melanoma cells (B16B15b) showed augmenting levels of HPSE‐1 protein expression in a time‐dependent manner. Secondly, B16B15b cells pre‐treated with HPSE‐1 showed a significant increase in the number of cells that invaded into the brain tissue. Finally, HPSE‐1 exposure‐augmented invasion depth in brain sections by brain‐metastatic melanoma cells. We concluded that applying this brain slice model can be beneficial to investigate HPSE‐1‐ related in vivo modalities in brain‐metastatic melanoma and brain invasion in general. These results also further emphasize the potential relevance of using this model to design therapies for controlling this type of cancer by blocking HPSE‐1 functionality.
- 15 November 2005
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 97 (2) , 217-225
Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model
Heparanase (HPSE‐1) is an endo‐β‐D‐glucuronidase that cleaves heparan sulfate (HS) chains of proteoglycans (HSPG), and its expression has been associated with increased cell growth, invasion, and angiogenesis of tumors as well as with embryogenesis and tissue development. Since metastatic cancer cells express HPSE‐1, we have developed an orthotopic brain slice model to study HPSE‐1 involvement in brain‐metastatic melanoma. This model allows for the characterization of tumor cell invasion at both quantitative and qualitative levels. Brain‐metastatic melanoma cells (B16B15b) showed augmenting levels of HPSE‐1 protein expression in a time‐dependent manner. Secondly, B16B15b cells pre‐treated with HPSE‐1 showed a significant increase in the number of cells that invaded into the brain tissue. Finally, HPSE‐1 exposure‐augmented invasion depth in brain sections by brain‐metastatic melanoma cells. We concluded that applying this brain slice model can be beneficial to investigate HPSE‐1‐ related in vivo modalities in brain‐metastatic melanoma and brain invasion in general. These results also further emphasize the potential relevance of using this model to design therapies for controlling this type of cancer by blocking HPSE‐1 functionality.
- 11 August 2004
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 93 (2) , 215-223
Dominant‐negative CREB inhibits heparanase functionality and melanoma cell invasion
Heparanase (HPSE-1) is an endo-β-d-glucuronidase involved in the degradation of cell-surface/extracellular matrix heparan sulfate (HS) in normal and neoplastic tissues. HPSE-1 represents the first example of purification and cloning of a mammalian HS-degradative enzyme. Elevated HPSE-1 levels are known to be associated with metastatic cancers, directly implicating HPSE-1 in metastatic events. The purpose of this study was to determine the role of cAMP response element-binding protein (CREB) in modulating HPSE-1-mediated effects on human melanoma cell invasion. Highly invasive, brain-metastatic melanoma cells (70W) were transfected with the dominant-negative CREB (KCREB) and subsequently analyzed for changes in their HPSE-1 content, functionality, and cell invasive properties. KCREB-transfected cells showed a decrease in HPSE-1 mRNA expression and activity. This correlated with a significantly decreased invasion of these cells through Matrigel™-coated filters. Furthermore, adenoviral vectors containing the full-length human HPSE-1 cDNA in sense orientation (Ad-S/hep) were constructed to investigate CREB effects on HPSE-1. Restoration of HPSE-1 expression and functionality following Ad-S/hep infection of KCREB-transfected 70W cells recovered melanoma cell invasiveness. These results demonstrate that KCREB inhibits HPSE-1 and suggest that one of the roles CREB plays in the acquisition of melanoma cells metastatic phenotype is affecting HPSE-1 activity.
- 11 August 2004
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 93 (2) , 215-223
Dominant‐negative CREB inhibits heparanase functionality and melanoma cell invasion
Heparanase (HPSE-1) is an endo-β-d-glucuronidase involved in the degradation of cell-surface/extracellular matrix heparan sulfate (HS) in normal and neoplastic tissues. HPSE-1 represents the first example of purification and cloning of a mammalian HS-degradative enzyme. Elevated HPSE-1 levels are known to be associated with metastatic cancers, directly implicating HPSE-1 in metastatic events. The purpose of this study was to determine the role of cAMP response element-binding protein (CREB) in modulating HPSE-1-mediated effects on human melanoma cell invasion. Highly invasive, brain-metastatic melanoma cells (70W) were transfected with the dominant-negative CREB (KCREB) and subsequently analyzed for changes in their HPSE-1 content, functionality, and cell invasive properties. KCREB-transfected cells showed a decrease in HPSE-1 mRNA expression and activity. This correlated with a significantly decreased invasion of these cells through Matrigel™-coated filters. Furthermore, adenoviral vectors containing the full-length human HPSE-1 cDNA in sense orientation (Ad-S/hep) were constructed to investigate CREB effects on HPSE-1. Restoration of HPSE-1 expression and functionality following Ad-S/hep infection of KCREB-transfected 70W cells recovered melanoma cell invasiveness. These results demonstrate that KCREB inhibits HPSE-1 and suggest that one of the roles CREB plays in the acquisition of melanoma cells metastatic phenotype is affecting HPSE-1 activity.
- Open Access
- 1 April 2004
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 6 (2) , 154-165
Brain metastases in melanoma: Roles of neurotrophins
Brain metastasis, which occurs in 20% to 40% of all cancer patients, is an important cause of neoplastic morbidity and mortality. Successful invasion
- 1 April 2004
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 6 (2) , 154-165
Open AccessBrain metastases in melanoma: Roles of neurotrophins
Brain metastasis, which occurs in 20% to 40% of all cancer patients, is an important cause of neoplastic morbidity and mortality. Successful invasion
- 1 September 2003
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 9 (3) , 147-158
Brain-metastatic melanoma: a neurotrophic perspective
The brain is a unique microenvironment enclosed by the skull and maintaining a highly regulated vascular transport barrier. To metastasize to the brain, malignant tumor cells must attach to microvessel endothelial cells, invade the blood-brain barrier (BBB), and respond to brain survival and growth factors. Neurotrophins (NT) are important in brain invasion because they stimulate this process. In brain-metastatic melanoma cells, NT can promote invasion by enhancing the production of extracellular matrixdegradative enzymes such as heparanase, an enzyme capable of locally destroying both the extracellular matrix and the basement membrane of the BBB. We have examined human and murine melanoma cell lines exhibiting varying abilities to form brain metastases, and have found that they express low-affinity neurotrophin receptor p75NTR in relation to their brain-metastatic potentials. They do not, however, express trkA, the gene encoding the tyrosine kinase receptor TrkA, the high-affinity receptor for nerve growth factor (NGF), the prototypic NT. Presence of functional TrkC, the putative receptor for the invasion-promoting neurotrophin NT-3, was also expressed in these cells. Brain-metastatic melanoma cells can also produce autocrine factors and inhibitors that influence their growth, invasion, and survival in the brain. Synthesis of these factors may influence NT production by brain cells adjacent to the neoplastic invasion front, such as oligodendrocytes and astrocytes. In brain biopsies, we observed increased amounts of NGF and NT-3 in tumor-adjacent tissues at the invasion front of human melanoma tumors. Additionally, we found that astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing NT-regulated heparanase. Trophic, autocrine, and paracrine growth factors may therefore determine whether metastatic cells can successfully invade, colonize, and grow in the central nervous system (CNS).
- 1 September 2003
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 9 (3) , 147-158
Brain-metastatic melanoma: a neurotrophic perspective
The brain is a unique microenvironment enclosed by the skull and maintaining a highly regulated vascular transport barrier. To metastasize to the brain, malignant tumor cells must attach to microvessel endothelial cells, invade the blood-brain barrier (BBB), and respond to brain survival and growth factors. Neurotrophins (NT) are important in brain invasion because they stimulate this process. In brain-metastatic melanoma cells, NT can promote invasion by enhancing the production of extracellular matrixdegradative enzymes such as heparanase, an enzyme capable of locally destroying both the extracellular matrix and the basement membrane of the BBB. We have examined human and murine melanoma cell lines exhibiting varying abilities to form brain metastases, and have found that they express low-affinity neurotrophin receptor p75NTR in relation to their brain-metastatic potentials. They do not, however, express trkA, the gene encoding the tyrosine kinase receptor TrkA, the high-affinity receptor for nerve growth factor (NGF), the prototypic NT. Presence of functional TrkC, the putative receptor for the invasion-promoting neurotrophin NT-3, was also expressed in these cells. Brain-metastatic melanoma cells can also produce autocrine factors and inhibitors that influence their growth, invasion, and survival in the brain. Synthesis of these factors may influence NT production by brain cells adjacent to the neoplastic invasion front, such as oligodendrocytes and astrocytes. In brain biopsies, we observed increased amounts of NGF and NT-3 in tumor-adjacent tissues at the invasion front of human melanoma tumors. Additionally, we found that astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing NT-regulated heparanase. Trophic, autocrine, and paracrine growth factors may therefore determine whether metastatic cells can successfully invade, colonize, and grow in the central nervous system (CNS).
- 29 August 2003
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 91 (1) , 206-215
p75 neurotrophin receptor functions as a survival receptor in brain‐metastatic melanoma cells
The p75 neurotrophin receptor (p75NTR), a common receptor for members of the neurotrophins (NT) family, was previously identified as a molecular determinant of brain metastasis. We have also reported that NT treatment of murine and human brain‐metastatic melanoma cells affects their invasive capacities and increases the production of heparanase, an important and unique extracellular matrix (ECM) degradative enzyme. Neurotrophism can be a survival‐support mechanism for brain‐metastatic cells and a survival assay was devised to mimic the growth limiting conditions of rapidly expanding metastatic tumors prior to neoangiogenesis. We report that p75NTR promoted the survival of brain‐metastatic melanoma cells but not melanocytes in stress cultures conditions. Secondly, melanoma cells fluorescently sorted for high p75NTR expression (p75NTR‐H cells) had an up to a 15‐fold greater survival than those sorted for low p75NTR expression (p75NTR‐L cells). Thirdly, cells overexpressing p75NTR associated with the growth fraction and provided these cells with an inherent growth advantage. Finally, we observed an increased survival of sorted p75NTR‐L cells, dependent upon treatment of NT members whose functional receptors are present on these cells. Together, these results delineate that p75NTR‐mediated trophic support profoundly affects competitive melanoma‐cell survival when the tumor cell microenvironment becomes growth limiting.
- 29 August 2003
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 91 (1) , 206-215
p75 neurotrophin receptor functions as a survival receptor in brain‐metastatic melanoma cells
The p75 neurotrophin receptor (p75NTR), a common receptor for members of the neurotrophins (NT) family, was previously identified as a molecular determinant of brain metastasis. We have also reported that NT treatment of murine and human brain‐metastatic melanoma cells affects their invasive capacities and increases the production of heparanase, an important and unique extracellular matrix (ECM) degradative enzyme. Neurotrophism can be a survival‐support mechanism for brain‐metastatic cells and a survival assay was devised to mimic the growth limiting conditions of rapidly expanding metastatic tumors prior to neoangiogenesis. We report that p75NTR promoted the survival of brain‐metastatic melanoma cells but not melanocytes in stress cultures conditions. Secondly, melanoma cells fluorescently sorted for high p75NTR expression (p75NTR‐H cells) had an up to a 15‐fold greater survival than those sorted for low p75NTR expression (p75NTR‐L cells). Thirdly, cells overexpressing p75NTR associated with the growth fraction and provided these cells with an inherent growth advantage. Finally, we observed an increased survival of sorted p75NTR‐L cells, dependent upon treatment of NT members whose functional receptors are present on these cells. Together, these results delineate that p75NTR‐mediated trophic support profoundly affects competitive melanoma‐cell survival when the tumor cell microenvironment becomes growth limiting.